Table 1.
Patient | Age | Sex | Organs involved | Eosinophilic counts (%) | ANCA titer |
---|---|---|---|---|---|
GG | 69 | male | lung, polyneuropathy | 19 | p-ANCA (1:80) |
GM* | 23 | male | lung, kidney | 23 | c-ANCA (1:160) |
LM* | 57 | female | lung, polyneuropathy | 36 | p-ANCA (1:80) |
NB | 57 | female | lung, paranasal sinus | 13 | negative |
PF* | 43 | male | lung, skin, gastrointestinal | 32 | c-ANCA (1:160) |
SJ* | 56 | male | lung | 10 | negative |
VN* | 49 | female | lung | 6 | negative |
WI* | 48 | female | gastrointestinal, lung, skin | 35 | x-ANCA (1:80) |
*PBL from these patients were also used for functional apoptosis tests and for enzyme-linked immunosorbent assay for soluble CD95 of culture supernatants.